People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · AI / ML, Climate / Cleantech, Other Technology, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Snowflake Computing, Inc. | — | AI / ML | Growth/Late | $2.4B | $3.7B | 2012 |
| Sila Nanotechnologies, Inc. | — | Climate / Cleantech | Growth/Late | $1.3B | $4.5B | 2018 |
| Observe, Inc. | — | Other Technology | Series D+ | $269.8M | $1.1B | 2024 |
| Augment Computing, Inc. | — | Other Technology | Series D+ | $252.0M | $2.7B | 2023 |
| Ghost Locomotion Inc. | — | Other Technology | Series D+ | $202.8M | $888.2M | 2018 |
| Savanna Biotherapeutics, Inc. | — | Biotechnology | Series B | $37.3M | $61.7M | 2022 |
| Platfora, Inc. | — | Other Technology | Series B | $32.9M | $609.1M | 2011 |
| Laserlike, Inc. | — | Other Technology | Series B | $24.1M | $608.3M | 2015 |
| Clumio, Inc. | — | Other | Series A | $10.4M | $157.4M | 2017 |
Michael L. Speiser at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael L. Speiser on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John McMahon | 2 | 7 |
| John D. McMahon | 2 | 3 |
| Jeremy Burton | 2 | 2 |
| BYRON DEETER | 1 | 17 |
| Scott Weiss | 1 | 10 |
| Jeffrey W. Bird | 1 | 6 |
| Carl Eschenbach | 1 | 6 |
| Michael Speiser | 1 | 6 |
| Frank Slootman | 1 | 5 |
| Mark McLaughlin | 1 | 5 |
| Michael P. Scarpelli | 1 | 4 |
| Scott Dietzen | 1 | 4 |
| John L. Walecka | 1 | 4 |
| Sridhar Ramaswamy | 1 | 3 |
| Vivek Raghunathan | 1 | 3 |
| Robert Muglia | 1 | 3 |
| Brian Robins | 1 | 2 |
| Keith M Rabois | 1 | 2 |
| Jayshree Ullal | 1 | 2 |
| Kelly Kramer | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.